Programs
HIVES Summit 2026
Beyond the Wheel: Understanding Urticaria
24–25 October 2026 | JW Marriott, Chandigarh | Scientific Programme
DAY 1 (SATURDAY) | URTICARIA
| Time | Topic | Speaker |
| 9:00–10:00 |  Award Paper Presentations | Chairperson: Dr Vishal Thakur, Dr Vinod Kumar Hanumanthu Judges: Dr VK Mahajan | Dr Anubha Dev | Dr Sukhdeep Singh |
Chairpersons: Prof Sanjeev Handa | Prof GP Thami
| Time | Topic | Speaker |
| 10:00–10:30 |  KEYNOTE: Pathogenesis of Chronic Spontaneous Urticaria: Updates on Mechanisms, Mediators and Biomarkers | Dr Kiran Godse | Dr Abhishek De |
SESSION 1 | Pathophysiology and Diagnosis
Chairpersons: Prof GS Verma | Dr Sumir Kumar | Dr Vinod Sharma
| Time | Topic | Speaker |
| 10:30–10:45 | Mast Cell Heterogeneity and Functional Endotypes in CSU | Dr Prabhakar M Sangolli |
| 10:45–11:00 | The CSU susceptibility triad: host genetics, microbiome and environmental triggers | Dr Hitaishi Mehta |
| 11:00–11:15 | Blood Investigations in CSU: What is Worth Ordering in 2026? | Dr Ramesh Bhatt |
| 11:15–11:45 am | Inauguration Ceremony followed by High Tea | Chairpersons: Prof Sanjeev Handa | Prof GP Thami |
SESSION 2 | Endotyping and Clinical Decision-Making
Chairpersons: Dr Guneet Kaur | Dr. Anuradha Bhatia
| Time | Topic | Speaker |
| 11:45–12:00 | Artificial Intelligence in Urticaria: Opportunities and Limitations in Practice | Dr Yashdeep Pathania |
| 12:00–12:15 | Endotyping in CSU: Pros, Cons and Clinical Utility | Dr Pavel Kolkhir |
| 12:15–12:40 |  DEBATE: Endotyping Before Treating CSU Should be Standard of Care — Routine Omalizumab Without Workup is No Longer Acceptable | Dr Sejal Jain / Dr Roshini N |
SESSION 3 | Chronic Inducible Urticaria
Chairpersons: Prof Dimple Chopra | Dr Manju Daroch | Dr Pushpinder Chauhan
| Time | Topic | Speaker |
| 12:40–1:00 | Pathogenesis of Chronic Inducible Urticaria: How Different from CSU? | Prof Michael Rudenko |
| 1:00–1:20 | Diagnostic Tests and Provocation Thresholds in CIU: Practical Applications | Dr Divya Bhatia |
| 1:20–1:40 | Management of CIU: Omalizumab Response, Standardised Endpoints and Evidence Gaps | Dr Kiran Godse |
| 1:40–2:30 pm | Lunch |
SESSION 4 | Urticaria and Comorbidities
Chairpersons: Prof Sanjeev Gupta | Dr Rajwinder Singh | Dr Payal Chauhan
| Time | Topic | Speaker |
| 2:30–2:50 | Metabolic Syndrome and Systemic Comorbidities in Chronic Urticaria | Dr Janaani P |
| 2:50–3:10 | Sleep Disorders and Mental Health in Chronic Urticaria: Impact on Mortality | Dr Ivan Cherrez-Ojeda |
| 3:10–4:00 |  PANEL: Managing CSU Beyond the Skin: Comorbidities, Quality of Life and Unmet Needs | Moderator: Dr Abhishek De Panellists: Dr Kiran Godse | Dr Tejinder Kaur | Dr Mukesh Girdhar | Dr Sri Ram | Dr Shikha Shah |
SESSION 5 | UCARE Meet
Chairpersons: Dr SD Mehta | Dr Jasleen Kaur
| Time | Topic | Speaker |
| 4:00–4:30 | Centre Updates: Research, Challenges and Patient Outcomes | Dr M Sendhil Kumaran | Dr Indrashish Podder | Dr Abhishek De | Dr Kiran Godse | Dr Tejinder Kaur | Dr Ramesh Bhatt (5 min each) |
| 4:30–4:40 | How to Become a UCARE Centre: Process and Advantages | Dr M Sendhil Kumaran |
| 4:40–4:50 | Latest UCARE Guidelines: Feasibility in the Indian Scenario | Dr Kiran Godse |
| 4:50–5:00 | Upcoming UCARE Projects and Collaborative Opportunities | Dr Abhishek De |
| 4:00–5:00 pm | Poster Walk and Quiz Prelims | TBD |
DAY 2 (SUNDAY)
| Time | Topic | Speaker |
| 8:30–9:30 am | Quiz Finals | Dr Hitaishi Mehta | Dr Narayanan B |
SESSION 1 | Urticaria Therapeutics
Chairpersons: Dr Rohit Bansal | Dr Vivek Malhotra
| Time | Topic | Speaker |
| 9:30–9:50 | Patient-Reported Outcomes and Quality of Life in Chronic Urticaria | Dr Tarun Narang |
| 9:50–10:10 | DEBATE: Updosing Antihistamines in CSU: Outdated Step or Still Clinically Relevant? | Dr Apoorva Sharma / Dr Ishita Kaushal |
Chairpersons: Dr Mala Bhalla | Dr Rajan Gupta
| 10:10–10:30 | Omalizumab in Refractory CSU: Real-World Experience and Predictors of Response | Dr M Sendhil Kumaran |
| 10:30–10:50 | Small Molecules in Urticaria: BTK Inhibitors — Mechanism, Efficacy and Safety Signals | Dr Mukesh Girdhar |
| 10:50–11:10 | Future of Urticaria Treatment: Mast Cell Silencing, Siglec-8 and KIT Antagonists | Dr Indrashish Podder |
SESSION 2 | Paediatric Allergy and Angioedema
Chairpersons: Dr PS Walia | Dr K S Mehta
| Time | Topic | Speaker |
| 11:10–11:25 | Paediatric Urticaria: Approach, Diagnostic Nuances and Management Gaps | Dr Biju Vasudevan |
| 11:25–11:40 | Approach to a Case of Angioedema: Algorithmic Evaluation | Dr Yasmeen J Bhat |
| 11:40–11:55 | Hereditary Angioedema: Updates, New Therapies and Guidelines | Dr Ankur Jindal |
Chairpersons: Dr Rajasmita Bhattacharjee | Dr Samipa Mukherjee
| 11:55–12:10 | Paediatric Drug Rash: Recognition and Management | Dr Mala Bhalla | |
| 12:10–12:50 | PANEL: Challenging Cases in Paediatrics: Urticaria, Angioedema and Their Mimics | Moderator: Dr Ankur Jindal Panellists: Dr VK Mahajan | Prof Rashmi Sarkar | Dr Deepti Suri | Prof Sunil Dogra | Dr Rahul Mahajan | |
| 12:50–1:50 pm | Lunch |
SESSION 3 | Severe Cutaneous Adverse Drug Reactions
Chairpersons: Dr Sukhjot Kaur | Dr Pushpinder Chauhan
| Time | Topic | Speaker |
| 1:50–2:10 | SCARs: Pathogenesis Updates, Prognostic Markers and Scoring Systems | Dr Vijay Aithal |
| 2:10–2:30 | DRESS Syndrome: Recognition, Workup, Systemic Involvement and Outcomes | Dr Laxmisha Chandrashekhar |
| 2:30–2:50 | SJS-TEN: Clinical Spectrum, Mimics and Evidence-Based Management | Prof Davinder Parsad |
Chairpersons: Dr M Sendhil Kumaran | Dr Sachin Kore
| 2:50–3:10 | Drug Rechallenge After SCARs: Principles, Risk Stratification and Practice | Prof M Ramam |
| 3:10–3:30 | Quality of Life in SCARs | Dr Sheetanshu Kumar |
| 3:30–4:10 | PANEL: Challenging Cases of SCARs: Multidisciplinary Perspectives | Moderator: Dr Vinay Keshavamurthy Panellists: Dr Laxmisha Chandrashekhar | Dr Dipankar De | Dr Abhishek Bhardwaj | Dr Maleeka Sachdeva | Dr Roma Pandhi | Dr Nitin Lade |
| 4:10–4:30 pm | Valedictory Address, Prize Distribution and Vote of Thanks |